✦ LIBER ✦

T1196 Twice-Daily Dosing of Balsalazide Tablets 3.3 G Is Safe and Effective in the Treatment of Mild-to-Moderate Ulcerative Colitis

✍ Scribed by Scherl, Ellen J.; Pruitt, Ron E.; Gordon, Glenn L.; Lamet, Mark; Shaw, Audrey L.; Huang, Shirley; Mareya, Shadreck M.; Forbes, William P.

Book ID: 122450488
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 94 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)62394-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T1152 Balsalazide Tablets 3.3g Twice Dai

T1152 Balsalazide Tablets 3.3g Twice Daily Improves Signs and Symptoms of Mild-to-Moderate Ulcerative Colitis

✍ Bosworth, Brian P.; Pruitt, Ronald E.; Gordon, Glenn L.; Lamet, Mark; Shaw, Audr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 103 KB

A randomized, double blind, dose-respons

A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis

✍ Douglas S Levine; Dennis S Riff; Ronald Pruitt; Lawrence Wruble; George Koval; D 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 307 KB

P040 ONCE-OR TWICE-DAILY MMX MESALAZINE

P040 ONCE-OR TWICE-DAILY MMX MESALAZINE (2.4G/DAY) IS EFFECTIVE FOR THE MAINTENANCE OF REMISSION OF MILD-TO-MODERATE ULCERATIVE COLITIS REGARDLESS OF THE MESALAZINE DOSE OR REGIMEN USED TO INDUCE REMISSION

✍ J.F. Colombel; R. Diebold; R. Karlstadt; K. Barrett; R. Joseph 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 73 KB

Ciclesonide is well tolerated and has mi

Ciclesonide is well tolerated and has minimal oropharyngeal side effects at once-daily doses of 80 $mu;g, 160 $mu;g, and 320 $mu;g in the treatment of patients with mild-to-moderate asthma*1

✍ BERGER, W 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB